Martin Anlauf practices in Duesseldorf, Germany. Anlauf is rated as an Advanced expert by MediFind in the treatment of Somatostatinoma. He is also highly rated in 12 other conditions, according to our data. His top areas of expertise are Multiple Endocrine Neoplasia Type 1, Zollinger-Ellison Syndrome, Neuroendocrine Tumor, and Multiple Endocrine Neoplasia.
His clinical research consists of co-authoring 73 peer reviewed articles in the past 15 years. In particular, he has co-authored 3 articles in the study of Somatostatinoma.
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.